Next Issue
Volume 2, December
Previous Issue
Volume 2, June
 
 

Gout Urate Cryst. Depos. Dis., Volume 2, Issue 3 (September 2024) – 5 articles

Cover Story (view full-size image): Age-related calcification is an increasing concern, impacting tissues throughout the body and affecting millions of people. This review examines the current understanding of how aging contributes to calcification in various human tissues. Additionally, we explore the murine models that have proven valuable for investigating the complexities of this process. Finally, we delve into the molecular mechanisms by which aging influences calcification, including cellular senescence, reduced pyrophosphate levels, and heightened oxidative stress and pro-mineralizing cytokines. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
40 pages, 7298 KiB  
Conference Report
The 15th European Crystal Network (ECN) Workshop—2024 ECN Abstract Proceedings
by Frédéric Lioté, Fernando Perez-Ruiz, Hang-Korng Ea, Tristan Pascart, Tony Merriman and Alexander So
Gout Urate Cryst. Depos. Dis. 2024, 2(3), 275-314; https://doi.org/10.3390/gucdd2030021 - 19 Sep 2024
Viewed by 794
Abstract
15th Anniversary this year: the ECN workshop is set up in Paris, down town. Every year ECN workshop offers a unique opportunity for clinicians and researchers interested in crystals, inflammation, crystal-induced diseases including gout, to present their latest results and discuss novel concepts. [...] Read more.
15th Anniversary this year: the ECN workshop is set up in Paris, down town. Every year ECN workshop offers a unique opportunity for clinicians and researchers interested in crystals, inflammation, crystal-induced diseases including gout, to present their latest results and discuss novel concepts. Twenty nine out of 52 accepted abstracts are reported here. Full article
Show Figures

Figure 1

9 pages, 2140 KiB  
Review
Periarticular Calcifications: Clinical Features and Treatment Options
by Romain Dalla-Torre, Benoit Le Goff and Christelle Darrieutort-Laffite
Gout Urate Cryst. Depos. Dis. 2024, 2(3), 266-274; https://doi.org/10.3390/gucdd2030020 - 2 Sep 2024
Viewed by 810
Abstract
Periarticular calcifications are a common condition for rheumatologists. They are characterized by deposition of carbonated apatite in tendons or connective tissues around joints. It most commonly affects patients between 30 and 60, and the main location is the shoulder (rotator cuff tendons), followed [...] Read more.
Periarticular calcifications are a common condition for rheumatologists. They are characterized by deposition of carbonated apatite in tendons or connective tissues around joints. It most commonly affects patients between 30 and 60, and the main location is the shoulder (rotator cuff tendons), followed by the hip. Although the disease is frequent, factors associated with the appearance of the deposits or their spontaneous resorption remain unclear. In this review, we will summarize the available data about mechanisms underlying the constitution of the deposits and their resorption and describe the various affected sites and the associated symptoms. In the last part, we will discuss current treatment options. Full article
Show Figures

Figure 1

14 pages, 2677 KiB  
Article
Obesity-Associated Hyperuricemia in Female Mice: A Reevaluation
by Andrew P. Giromini, Sonia R. Salvatore, Brooke A. Maxwell, Sara E. Lewis, Michael R. Gunther, Marco Fazzari, Francisco J. Schopfer, Roberta Leonardi and Eric E. Kelley
Gout Urate Cryst. Depos. Dis. 2024, 2(3), 252-265; https://doi.org/10.3390/gucdd2030019 - 30 Aug 2024
Viewed by 883
Abstract
Many preclinical reports have coalesced to identify a strong association between obesity and increased levels of uric acid (UA) in tissues and, importantly, in the circulation (hyperuricemia). Unfortunately, nearly all these studies were conducted with male mice or, in one case, female mice [...] Read more.
Many preclinical reports have coalesced to identify a strong association between obesity and increased levels of uric acid (UA) in tissues and, importantly, in the circulation (hyperuricemia). Unfortunately, nearly all these studies were conducted with male mice or, in one case, female mice without a side-by-side male cohort. Therefore, the relationship between obesity and hyperuricemia in female mice remains undefined. This lack of clarity in the field has considerable impact as the downstream effects of obesity and allied hyperuricemia are extensive, resulting in many comorbidities including cardiovascular dysfunction, chronic kidney disease, and nonalcoholic fatty liver disease (NAFLD). Herein we begin to address this issue by revealing phenotypic and metabolic responses to diet-induced obesity (DIO) in a side-by-side male vs. female C57BL/6J study. Beginning at 6 weeks of age, mice were exposed to either an obesogenic diet (60% calories from fat) or control diet (10% calories from fat) for 19 weeks. Similar to numerous reported observations with the 60% diet, male mice experienced significant weight gain over time, elevated fasting blood glucose, impaired glucose tolerance and significantly elevated circulating uric acid levels (2.54 ± 0.33 mg/dL) compared to age-matched lean male controls (1.53 ± 0.19 mg/dL). As expected, the female mice experienced a slower rate of weight gain compared to the males; however, they also developed elevated fasting blood glucose and impaired glucose tolerance compared to age-matched lean controls. Countervailing our previous report whereby the control diet for the female-only study was vivarium standard chow (18% calories from fat), the obese female mice did demonstrate significantly elevated circulating UA levels (2.55 ± 0.15 mg/dL) compared to the proper control (1.68 ± 0.12 mg/dL). This affirms that the choice of control diet is crucial for reaching durable conclusions. In toto, these results, for the first time, reveal elevated circulating UA to be a similar long-term response to obesogenic feeding for both males and females and mirrors clinical observations demonstrating hyperuricemia in obesity for both sexes. Full article
Show Figures

Figure 1

16 pages, 732 KiB  
Review
Age-Associated Calcification: Insights from Murine Models
by Sonia Nasi, Mario Romani and Nathalie Busso
Gout Urate Cryst. Depos. Dis. 2024, 2(3), 236-251; https://doi.org/10.3390/gucdd2030018 - 6 Aug 2024
Viewed by 1126
Abstract
Calcification refers to the deposition of calcium-containing crystals either intracellularly or within the extracellular matrix. Physiologic calcification is a normal process occurring during bone and tooth development and growth. In contrast, pathologic calcification occurs in soft tissues that typically do not undergo mineralization, [...] Read more.
Calcification refers to the deposition of calcium-containing crystals either intracellularly or within the extracellular matrix. Physiologic calcification is a normal process occurring during bone and tooth development and growth. In contrast, pathologic calcification occurs in soft tissues that typically do not undergo mineralization, such as blood vessels, cartilage, tendons, and skin. Pathological calcification is significantly associated with tissue impairment and the development of secondary diseases, such as atherosclerosis, osteoarthritis, tendinopathy, and skin ulcers. Aging, a natural process linked to numerous pathologic conditions, is one of the most recognized risk factors for pathological calcification. In this manuscript, we review the current state of knowledge regarding the role of aging in calcification across different tissues. We focus on the mechanisms activated during normal aging, including cellular senescence, decreased pyrophosphate levels, increased secretion of extracellular vesicles, elevated oxidative stress, and higher levels of pro-mineralizing cytokines, all of which can contribute to pathological calcification. Finally, we discuss the available animal models used to study the impact of aging on calcification. Full article
Show Figures

Figure 1

16 pages, 954 KiB  
Review
Gout Basic Research: 2023 in Review
by Maria Muntiu, Leo A. B. Joosten and Tania O. Crişan
Gout Urate Cryst. Depos. Dis. 2024, 2(3), 220-235; https://doi.org/10.3390/gucdd2030017 - 31 Jul 2024
Viewed by 1481
Abstract
Gout is a prevalent form of inflammatory arthritis caused by the crystallization of uric acid in the joints and soft tissues, leading to acute, painful attacks. Activation of the NLRP3 inflammasome in mononuclear cells, along with inflammasome-independent pathways, is responsible for the inflammatory [...] Read more.
Gout is a prevalent form of inflammatory arthritis caused by the crystallization of uric acid in the joints and soft tissues, leading to acute, painful attacks. Activation of the NLRP3 inflammasome in mononuclear cells, along with inflammasome-independent pathways, is responsible for the inflammatory phenotype in gout. Research into the different aspects of gout pathophysiology and potential treatment options is ongoing. This review highlights some of the basic research published in the 12 months following the 2022 Gout, Hyperuricemia, and Crystal-Associated Disease Network (G-CAN) conference and focuses on mechanisms of inflammation, encompassing pro- and anti-inflammatory pathways, as well as the exploration of various biological systems, such as single-cell transcriptomics, proteomics, metabolomics, and microbiome analyses. Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop